Predicting acute and persistent neuropathy associated with oxaliplatin.
about
Pain in cancer survivorsComparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral NeuropathyClinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).Self-management of oxaliplatin-related peripheral neuropathy in colorectal cancer survivorsOxaliplatin-related neuropathy in Indian patients - no difference between generic and original molecules.Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors.Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review.Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics.Impact of physical exercise in cancer survivors during and after antineoplastic treatments.The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review.Hyperacute peripheral neuropathy is a predictor of oxaliplatin-induced persistent peripheral neuropathy.Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain.
P2860
Q33650576-88E71C52-8B62-490D-B366-472980387C60Q33711444-6E53EBE8-E176-4A58-8005-386BA968DF38Q33744706-A6CF4E2B-075D-4018-B6E3-2B4BDECF4EDDQ35796623-94909EA5-F7FD-4CB3-BDDF-69764C123622Q36162504-0795CE65-98BF-437C-BE92-DF65C4EE6377Q37155944-5624E514-A2D4-4E5C-92DE-E60F6A123EADQ37584933-36D939C2-26FC-42F8-9290-D304E31C3102Q37744263-99419873-AB86-43D4-B6CE-CFB5B17C7D1BQ38707400-0AF1BB08-9738-48B7-BD27-E88A593C561BQ38931361-CA4D6996-3709-4D35-AB40-18261881EC2CQ51732172-5A00047D-8133-4D41-9066-29B175B3D87CQ52591422-DD2CABD2-72F9-4705-A1B1-CA90A1A2D321Q53645807-CA7D16B7-26E6-4170-9762-0ED3E7D5B816Q55364011-759A715D-BD0A-41E1-BD64-968C1B3F1C20
P2860
Predicting acute and persistent neuropathy associated with oxaliplatin.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Predicting acute and persistent neuropathy associated with oxaliplatin.
@ast
Predicting acute and persistent neuropathy associated with oxaliplatin.
@en
type
label
Predicting acute and persistent neuropathy associated with oxaliplatin.
@ast
Predicting acute and persistent neuropathy associated with oxaliplatin.
@en
prefLabel
Predicting acute and persistent neuropathy associated with oxaliplatin.
@ast
Predicting acute and persistent neuropathy associated with oxaliplatin.
@en
P2093
P2860
P1476
Predicting acute and persistent neuropathy associated with oxaliplatin.
@en
P2093
Carolyn E Behrendt
Harry Openshaw
Linh M Alejandro
Stephen Shibata
P2860
P304
P356
10.1097/COC.0B013E318246B50D
P577
2013-08-01T00:00:00Z